150 related articles for article (PubMed ID: 32998995)
1. β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism.
Belleri M; Paganini G; Coltrini D; Ronca R; Zizioli D; Corsini M; Barbieri A; Grillo E; Calza S; Bresciani R; Maiorano E; Mastropasqua MG; Annese T; Giacomini A; Ribatti D; Casas J; Levade T; Fabrias G; Presta M
Cancer Res; 2020 Nov; 80(22):5011-5023. PubMed ID: 32998995
[TBL] [Abstract][Full Text] [Related]
2. The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells.
Capoferri D; Chiodelli P; Corli M; Belleri M; Scalvini E; Mignani L; Guerra J; Grillo E; De Giorgis V; Manfredi M; Presta M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445731
[TBL] [Abstract][Full Text] [Related]
3. Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase.
Belleri M; Chiodelli P; Corli M; Capra M; Presta M
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188675. PubMed ID: 34974112
[TBL] [Abstract][Full Text] [Related]
4. β-Galactosylceramidase in cancer: friend or foe?
Presta M
Trends Cancer; 2021 Nov; 7(11):974-977. PubMed ID: 34456156
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease.
Zizioli D; Guarienti M; Tobia C; Gariano G; Borsani G; Bresciani R; Ronca R; Giacopuzzi E; Preti A; Gaudenzi G; Belleri M; Di Salle E; Fabrias G; Casas J; Ribatti D; Monti E; Presta M
Biochim Biophys Acta; 2014 Apr; 1842(4):665-75. PubMed ID: 24463171
[TBL] [Abstract][Full Text] [Related]
6. Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos.
Guerra J; Belleri M; Paiardi G; Tobia C; Capoferri D; Corli M; Scalvini E; Ghirimoldi M; Manfredi M; Wade RC; Presta M; Mignani L
Comput Struct Biotechnol J; 2024 Dec; 23():1397-1407. PubMed ID: 38596316
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma.
Capoferri D; Mignani L; Manfredi M; Presta M
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474307
[TBL] [Abstract][Full Text] [Related]
8. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
9. GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.
Senkevich K; Zorca CE; Dworkind A; Rudakou U; Somerville E; Yu E; Ermolaev A; Nikanorova D; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Grenn FP; Chiang MSR; Sardi SP; Vanderperre B; Blauwendraat C; Trempe JF; Fon EA; Durcan TM; Alcalay RN; Gan-Or Z
Brain; 2023 May; 146(5):1859-1872. PubMed ID: 36370000
[TBL] [Abstract][Full Text] [Related]
10. Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
Ronca R; Di Salle E; Giacomini A; Leali D; Alessi P; Coltrini D; Ravelli C; Matarazzo S; Ribatti D; Vermi W; Presta M
Mol Cancer Ther; 2013 Dec; 12(12):2760-71. PubMed ID: 24130051
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].
Tsai HE; Wu JC; Kung ML; Liu LF; Kuo LH; Kuo HM; Chen SC; Chan EC; Wu CS; Tai MH; Liu GS
PLoS One; 2013; 8(3):e59345. PubMed ID: 23536873
[TBL] [Abstract][Full Text] [Related]
12. DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.
Haynes TA; Filippov V; Filippova M; Yang J; Zhang K; Duerksen-Hughes PJ
Biochim Biophys Acta; 2012 Jul; 1821(7):943-53. PubMed ID: 22349266
[TBL] [Abstract][Full Text] [Related]
13. Ceramide synthase 2-C
Zhang X; Sakamoto W; Canals D; Ishibashi M; Matsuda M; Nishida K; Toyoshima M; Shigeta S; Taniguchi M; Senkal CE; Okazaki T; Yaegashi N; Hannun YA; Nabe T; Kitatani K
FASEB J; 2021 Feb; 35(2):e21287. PubMed ID: 33423335
[TBL] [Abstract][Full Text] [Related]
14. DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.
Peng J; Chen B; Shen Z; Deng H; Liu D; Xie X; Gan X; Xu X; Huang Z; Chen J
Int J Clin Exp Pathol; 2015; 8(9):11042-50. PubMed ID: 26617822
[TBL] [Abstract][Full Text] [Related]
15. Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.
Bizzozero L; Cazzato D; Cervia D; Assi E; Simbari F; Pagni F; De Palma C; Monno A; Verdelli C; Querini PR; Russo V; Clementi E; Perrotta C
Cell Death Differ; 2014 Apr; 21(4):507-20. PubMed ID: 24317198
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
[TBL] [Abstract][Full Text] [Related]
17. Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases.
Filippov V; Song MA; Zhang K; Vinters HV; Tung S; Kirsch WM; Yang J; Duerksen-Hughes PJ
J Alzheimers Dis; 2012; 29(3):537-47. PubMed ID: 22258513
[TBL] [Abstract][Full Text] [Related]
18. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
[TBL] [Abstract][Full Text] [Related]
19. Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Montfort A; Bertrand F; Rochotte J; Gilhodes J; Filleron T; Milhès J; Dufau C; Imbert C; Riond J; Tosolini M; Clarke CJ; Dufour F; Constantinescu AA; Junior NF; Garcia V; Record M; Cordelier P; Brousset P; Rochaix P; Silvente-Poirot S; Therville N; Andrieu-Abadie N; Levade T; Hannun YA; Benoist H; Meyer N; Micheau O; Colacios C; Ségui B
Cancer Immunol Res; 2021 May; 9(5):568-582. PubMed ID: 33727246
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
